• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于治疗反应评估的CT肿瘤测量:一维、二维和容积技术的比较——初步观察

CT tumor measurement for therapeutic response assessment: comparison of unidimensional, bidimensional, and volumetric techniques initial observations.

作者信息

Prasad Srinivasa R, Jhaveri Kartik S, Saini Sanjay, Hahn Peter F, Halpern Elkan F, Sumner James E

机构信息

Department of Radiology, Massachusetts General Hospital and Harvard Medical School, 32 Fruit St, White 270-E, Boston, MA 02114, USA.

出版信息

Radiology. 2002 Nov;225(2):416-9. doi: 10.1148/radiol.2252011604.

DOI:10.1148/radiol.2252011604
PMID:12409574
Abstract

PURPOSE

To compare unidimensional, bidimensional, and volumetric techniques for evaluation of treatment response in patients with liver metastases from breast cancer in a phase III clinical trial.

MATERIALS AND METHODS

Helical computed tomographic (CT) studies in 38 patients with liver metastases from breast cancer who were enrolled in a phase III clinical trial were evaluated before treatment and at 6 months after treatment. Two subspecialty radiologists measured all lesions on transverse CT scans with use of electronic calipers according to both unidimensional and bidimensional criteria. Volumetric measurements were made by tracing individual lesions. Measurements of individual lesions were summed to obtain patient response, which was categorized as complete response, disappearance of lesions; partial response, greater than 30% decrease in tumor diameter (unidimensional), greater than 50% reduction in tumor area (bidimensional), or greater than 65% reduction in tumor volume (volumetric); disease progression, greater than 20% increase in tumor diameter, greater than 25% increase in tumor area, or greater than 73% increase in tumor volume: or stable disease (size response other than that of complete response, partial response, or disease progression).

RESULTS

In 37 patients, there was concordant treatment response with use of unidimensional and bidimensional techniques. Volumetric measurement produced results different from those of the unidimensional and bidimensional techniques in 12 and 13 patients, respectively. In six patients with partial response per unidimensional and bidimensional criteria, the response based on the volumetric technique was stable disease. In two patients with stable disease per bidimensional and unidimensional criteria, the response was partial response by volumetric measurement. In four patients with disease progression per bidimensional and unidimensional criteria, the response was stable disease per volumetric criteria.

CONCLUSION

Volumetric measurement of tumor burden gives different results for treatment response compared with that of the unidimensional or bidimensional technique in a considerable proportion of patients.

摘要

目的

在一项III期临床试验中,比较单维度、双维度和容积技术评估乳腺癌肝转移患者治疗反应的情况。

材料与方法

对38例参加III期临床试验的乳腺癌肝转移患者在治疗前和治疗后6个月进行螺旋计算机断层扫描(CT)检查。两名专科放射科医生根据单维度和双维度标准,使用电子卡尺在横断位CT扫描上测量所有病灶。通过描绘各个病灶进行容积测量。将各个病灶的测量值相加得出患者的反应,分为完全缓解(病灶消失)、部分缓解(肿瘤直径单维度测量下降超过30%,肿瘤面积双维度测量缩小超过50%,或肿瘤容积测量缩小超过65%)、疾病进展(肿瘤直径增加超过20%,肿瘤面积增加超过25%,或肿瘤容积增加超过73%)或疾病稳定(除完全缓解、部分缓解或疾病进展之外的大小反应)。

结果

37例患者使用单维度和双维度技术得出的治疗反应一致。容积测量分别在12例和13例患者中得出与单维度和双维度技术不同的结果。在根据单维度和双维度标准判定为部分缓解的6例患者中,基于容积技术的反应为疾病稳定。在根据双维度和单维度标准判定为疾病稳定的2例患者中,容积测量显示为部分缓解。在根据双维度和单维度标准判定为疾病进展的4例患者中,容积标准显示为疾病稳定。

结论

在相当一部分患者中,肿瘤负荷的容积测量得出的治疗反应结果与单维度或双维度技术不同。

相似文献

1
CT tumor measurement for therapeutic response assessment: comparison of unidimensional, bidimensional, and volumetric techniques initial observations.用于治疗反应评估的CT肿瘤测量:一维、二维和容积技术的比较——初步观察
Radiology. 2002 Nov;225(2):416-9. doi: 10.1148/radiol.2252011604.
2
Radiological measurement of breast cancer metastases to lung and liver: comparison between WHO (bidimensional) and RECIST (unidimensional) guidelines.乳腺癌肺和肝转移的放射学测量:WHO(二维)和RECIST(一维)指南的比较
J Comput Assist Tomogr. 2003 May-Jun;27(3):380-4. doi: 10.1097/00004728-200305000-00014.
3
Comparison of treatment response classifications between unidimensional, bidimensional, and volumetric measurements of metastatic lung lesions on chest computed tomography.胸部计算机断层扫描中转移性肺病变的一维、二维和体积测量之间治疗反应分类的比较。
Acad Radiol. 2004 Dec;11(12):1355-60. doi: 10.1016/j.acra.2004.09.004.
4
Capecitabine in combination with docetaxel and epirubicin in patients with previously untreated, advanced breast carcinoma.卡培他滨联合多西他赛和表柔比星用于既往未接受过治疗的晚期乳腺癌患者。
Cancer. 2003 Mar 1;97(5):1174-80. doi: 10.1002/cncr.11203.
5
Phase II trial of capecitabine and weekly paclitaxel in patients with metastatic breast cancer previously treated with every-3-week taxane therapy.卡培他滨与每周一次紫杉醇用于先前接受每三周一次紫杉烷治疗的转移性乳腺癌患者的II期试验。
Clin Breast Cancer. 2007 Feb;7(6):465-70. doi: 10.3816/CBC.2007.n.003.
6
Phase II trial of capecitabine and weekly paclitaxel as first-line therapy for metastatic breast cancer.卡培他滨与每周一次紫杉醇作为转移性乳腺癌一线治疗的II期试验。
J Clin Oncol. 2006 Sep 20;24(27):4384-90. doi: 10.1200/JCO.2005.05.1383. Epub 2006 Aug 22.
7
Capecitabine and docetaxel in advanced breast cancer: analyses of a phase III comparative trial.卡培他滨与多西他赛治疗晚期乳腺癌:一项III期对比试验的分析
Oncology (Williston Park). 2002 Oct;16(10 Suppl 12):17-22.
8
Capecitabine with weekly paclitaxel for advanced breast cancer: a phase I dose-finding trial.卡培他滨联合每周一次紫杉醇治疗晚期乳腺癌:一项I期剂量探索试验。
Oncology. 2004;67(2):117-22. doi: 10.1159/000080997.
9
Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer: phase III trial results.在接受过蒽环类药物治疗的晚期乳腺癌患者中,卡培他滨联合多西他赛的联合疗法具有更好的生存率:III期试验结果
J Clin Oncol. 2002 Jun 15;20(12):2812-23. doi: 10.1200/JCO.2002.09.002.
10
Improved survival in advanced breast cancer with docetaxel and capecitabine in combination: biological synergy or an artefact of trial design?多西他赛与卡培他滨联合应用改善晚期乳腺癌患者生存率:生物学协同作用还是试验设计假象?
Eur J Cancer. 2002 Oct;38(15):1957-60. doi: 10.1016/s0959-8049(02)00167-3.

引用本文的文献

1
Automatic 3D Tracking of Liver Metastases: Follow-Up Assessment of Cancer Patients in Contrast-Enhanced MRI.肝脏转移瘤的自动三维跟踪:对比增强磁共振成像对癌症患者的随访评估
Bioengineering (Basel). 2025 Aug 12;12(8):874. doi: 10.3390/bioengineering12080874.
2
Comparison of histological response across patients with Ewing sarcoma treated with preoperative chemotherapy with or without preoperative radiotherapy.接受术前化疗加或不加术前放疗的尤因肉瘤患者组织学反应的比较。
Eur J Orthop Surg Traumatol. 2025 Jun 17;35(1):251. doi: 10.1007/s00590-025-04378-2.
3
Relationship between spleen volume and diameter for assessment of response to treatment on CT in patients with hematologic malignancies enrolled in clinical trials.
参与临床试验的血液系统恶性肿瘤患者中,脾脏体积与直径的关系用于评估CT上的治疗反应。
Abdom Radiol (NY). 2025 May 31. doi: 10.1007/s00261-025-05030-7.
4
Reliability of Automated RECIST 1.1 and Volumetric RECIST Target Lesion Response Evaluation in Follow-Up CT-A Multi-Center, Multi-Observer Reading Study.自动RECIST 1.1和容积RECIST靶病灶反应评估在随访CT中的可靠性——一项多中心、多观察者阅片研究
Cancers (Basel). 2024 Nov 29;16(23):4009. doi: 10.3390/cancers16234009.
5
A reduction in tumor volume exceeding 65% predicts a good histological response to neoadjuvant chemotherapy in patients with Ewing sarcoma.肿瘤体积缩小超过 65%预示着尤文肉瘤患者对新辅助化疗有良好的组织学反应。
Skeletal Radiol. 2024 Dec;53(12):2653-2664. doi: 10.1007/s00256-024-04702-7. Epub 2024 May 7.
6
Automated evaluation of masseter muscle volume: deep learning prognostic approach in oral cancer.自动化评估咬肌体积:口腔癌的深度学习预测方法。
BMC Cancer. 2024 Jan 24;24(1):128. doi: 10.1186/s12885-024-11873-y.
7
Intra- and Inter-Reader Variations in Lung Nodule Measurements: Influences of Nodule Size, Location, and Observers.肺结节测量中阅片者内部和阅片者间的差异:结节大小、位置及观察者的影响
Diagnostics (Basel). 2022 Sep 26;12(10):2319. doi: 10.3390/diagnostics12102319.
8
Comparison of CT Volumetry and RECIST to Predict the Treatment Response and Overall Survival in Gastric Cancer Liver Metastases.CT容积测量法与RECIST用于预测胃癌肝转移治疗反应及总生存期的比较
Taehan Yongsang Uihakhoe Chi. 2021 Jul;82(4):876-888. doi: 10.3348/jksr.2020.0085. Epub 2021 Mar 22.
9
Prospective Evaluation of Response Outcomes of Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer.局部晚期乳腺癌新辅助化疗反应结果的前瞻性评估
Cureus. 2022 Feb 2;14(2):e21831. doi: 10.7759/cureus.21831. eCollection 2022 Feb.
10
Volumetric measurements of target lesions: does it improve inter-reader variability for oncological response assessment according to RECIST 1.1 guidelines compared to standard unidimensional measurements?靶病灶的体积测量:与标准的一维测量相比,根据RECIST 1.1指南进行肿瘤反应评估时,它是否能降低阅片者间的变异性?
Pol J Radiol. 2021 Oct 22;86:e594-e600. doi: 10.5114/pjr.2021.111048. eCollection 2021.